Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2026-02-24 @ 5:50 AM
Study NCT ID:
NCT02141451
Status:
COMPLETED
Last Update Posted:
2020-02-19
First Post:
2014-05-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL
Sponsor:
Masonic Cancer Center, University of Minnesota
Organization: